Product NDC: | 0781-2119 |
Proprietary Name: | Bromocriptine Mesylate |
Non Proprietary Name: | bromocriptine mesylate |
Active Ingredient(s): | 5 mg/1 & nbsp; bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-2119 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017962 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19780628 |
Package NDC: | 0781-2119-01 |
Package Description: | 100 CAPSULE in 1 PACKAGE (0781-2119-01) |
NDC Code | 0781-2119-01 |
Proprietary Name | Bromocriptine Mesylate |
Package Description | 100 CAPSULE in 1 PACKAGE (0781-2119-01) |
Product NDC | 0781-2119 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bromocriptine mesylate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19780628 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Sandoz Inc |
Substance Name | BROMOCRIPTINE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |